TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Rohto Pharmaceutical Co ( (JP:4527) ) has shared an update.
Rohto Pharmaceutical Co., Ltd. has announced a decision by its Board of Directors to repurchase up to 2,174,300 of its own shares through an off-auction share repurchase transaction on the Tokyo Stock Exchange. This strategic move, amounting to a total repurchase price of approximately ¥4.99 billion, is part of the company’s efforts to enhance shareholder value and optimize its capital structure. The repurchase is set to occur on February 27, 2025, with the possibility of continuing acquisitions until April 30, 2025, depending on market conditions.
More about Rohto Pharmaceutical Co
Rohto Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and sale of health-related products. The company is known for its wide range of products including over-the-counter medicines, skincare, and health supplements, with a significant market presence in Japan and expanding globally.
YTD Price Performance: -14.49%
Average Trading Volume: 5,490
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.54B
Learn more about 4527 stock on TipRanks’ Stock Analysis page.